Sex differences in performance of fecal occult blood testing

American Journal of Gastroenterology

Volumn 105, Issue 11, 2010, Pages 2457-2464

  Brenner, Hermann ^a   Haug, Ulrike ^a   Hundt, Sabrina ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GUAIAC;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER SCREENING; COLON ADENOMA; COLONOSCOPY; COLORECTAL CANCER; EARLY DIAGNOSIS; FEMALE; GERMANY; HUMAN; MAJOR CLINICAL STUDY; MALE; OCCULT BLOOD TEST; PRIORITY JOURNAL; QUALITATIVE DIAGNOSIS; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; TUMOR VOLUME;

ADENOMA; AGED; COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FECES; FEMALE; GUAIAC; HUMANS; MALE; MIDDLE AGED; OCCULT BLOOD; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; SEX CHARACTERISTICS;

EID: 78149280477     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2010.301     Document Type: Article

References (33)

1. Levin B , Lieberman DA , McFarland B et al. Screening and surveillance forthe early detection of colorectal cancer and adenomatous polyps, 2008: ajoint guideline from the American Cancer Society, the US Multi-SocietyTask Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 2008 ; 134 : 1570-95.
2. Rex DK , Johnson DA , Anderson JC et al. American College of Gastroenterologyguidelines for colorectal cancer screening 2009. Am J Gastroenterol2009 ; 104 : 739-50.
3. Hewitson P , Glasziou P , Watson E et al. Cochrane systematic review ofcolorectal cancer screening using the fecal occult blood test (hemoccult): anupdate. Am J Gastroenterol 2008 ; 103 : 1541-9.
4. Allison JE , Sakoda LC , Levin TR et al. Screening for colorectal neoplasmswith new fecal occult blood tests: update on performance characteristics. J Natl Cancer Inst 2007 ; 99 : 1462-70.
5. Guittet L , Bouvier V , Mariotte N et al. Comparison of a guaiac based and animmunochemical faecal occult blood test in screening for colorectal cancerin a general average risk population. Gut 2007 ; 56 : 210-4.
6. Dancourt V , Lejeune C , Lepage C et al. Immunochemical faecal occultblood tests are superior to guaiac-based tests for the detection of colorectalneoplasms. Eur J Cancer 2008 ; 44 : 2254-8.
7. van Rossum LG , van Rijn AF , Laheij RJ et al. Random comparison of guaiacand immunochemical fecal occult blood tests for colorectal cancer in ascreening population. Gastroenterology 2008 ; 135 : 82-90.
8. Hol L , Wilschut JA , van Bollegooijen M et al. Screening for colorectalcancer: random comparison of guaiac and immunochemical faecal occultblood testing at diff erent cut-off levels. Br J Cancer 2009 ; 100 : 1103-10.
9. Hundt S , Haug U , Brenner H. Comparative evaluation of immunochemicalfecal occult blood tests for colorectal adenoma detection. Ann Intern Med2009 ; 150 : 162-9.
10. Morikawa T , Kato J , Yamaji Y et al. A comparison of the immunochemicalfecal occult blood test and total colonoscopy in the asymptomatic population. Gastroenterology 2005 ; 129 : 422-8.
11. Levi Z , Rozen P , Hazazi R et al. A quantitative immunochemical fecal occultblood test for colorectal neoplasia. Ann Intern Med 2007 ; 146 : 244-55.
12. Haug U , Hundt S , Brenner H. Quantitative immunochemical fecal occultblood testing for colorectal adenoma detection: evaluation in the targetpopulation of screening and comparison with qualitative tests. Am JGastroenterol 2010 ; 105 : 682-90.
13. Brenner H , Hoff meister M , Arndt V et al. Gender Differences in colorectalcancer: implications for age at initiation of screening. Br J Cancer2007 ; 96 : 828-31.
14. Rim SH , Seeff L , Ahmed F et al. Colorectal cancer incidence in the UnitedStates 1999-2004: an updated analysis of data from the National Programof Cancer Registries and the Surveillance, Epidemiology, and End ResultsProgram. Cancer 2009 ; 115 : 1967-76.
15. Regula J , Rupinski M , Kraszewska E et al. Colonoscopy in colorectalcancerscreening for detection of advanced neoplasia. N Engl J Med2006 ; 355 : 1863-72.
16. Brenner H , Hoff meister M , Stegmaier C et al. Risk of progression ofadvanced adenomas to colorectal cancer by age and sex: estimates based on840,149 screening colonoscopies. Gut 2007 ; 56 : 1585-9.
17. Nguyen SP , Bent S , Chen YH et al. Gender as a risk factor for advancedneoplasia and colorectal cancer. A systematic review and meta-analysis. Clin Gastroenterol Hepatol 2009 ; 7 : 676-81.
18. Altman DG , Bland JM. Diagnostic tests 2: predictive values. Br Med J1994 ; 309 : 102.
19. http://www.r-biopharm.com/product-site.php?product-id=39&. Accessed28 December 2009.
20. Morikawa T , Kato J , Yamaji Y et al. Sensitivity of immunochemicalfecal occult blood test to small colorectal adenomas. Am J Gastroenterol2007 ; 102 : 2259-64.
21. Rozen G , Levi Z , Hazazi R et al. Identification of colorectal adenomas by aquantitative immunochemical faecal occult blood screening test dependson adenoma characteristics, development threshold used and number oftests performed. Aliment Pharmacol Ther 2009 ; 29 : 906-17.
22. Myers AM , Saunders CRG , Chalmers DG. The haemoglobin level of elderlypeople. Lancet 1968 ; 2 : 261-3.
23. Levi Z , Rozen P , Hazazi R et al. Sensitivity, but not specificity, of a quantitativeimmunochemical fecal occult blood test for neoplasia is slightlyincreased by the use of low-dose aspirin NSAIDs, and anticoagulants. Am J Gastroenterol 2009 ; 104 : 933-8.
24. Meier R , Beglinger C , Dederding JP et al. influence of age, gender, hormonalstatus and smoking habits on colonic transit time. NeurogastroenterolMotil 1995 ; 7 : 235-8.
25. Sadik R , Abrahamsson H , Stotzer PO. Gender Differences in gut transitshown with a newly developed radiological procedure. Scand J Gastroenterol2003 ; 38 : 36-42.
26. Rao SS , Kuo B , McCallum RW et al. Investigation of colonic and whole guttransit with wireless motility capsule and radioopaque markers in constipation. Clin Gastroenterol Hepatol 2009 ; 7 : 537-44.
27. Brown LF , Fraser CG. Effect of delay in sampling on haemoglobin determinedby faecal immunochemical tests. Ann Clin Biochem 2008 ; 45 : 604-5.
28. Van Rossum LG , van Rijn AF , van Oijen MG et al. False negative fecaloccult blood tests due to delayed sample return in colorectal cancer screening. Int J Cancer 2009 ; 125 : 746-50.
29. Van Rijn JC , Reitsma JB , Stoker J et al. Polyp miss rate determined by tandemcolonoscopy: a systematic review. Am J Gastroenterol 2006 ; 101 : 343-50.
30. Brenner H , Haug U , Hundt S. Inter-test agreement and quantitativecross-validation of immunochromatographical fecal occult blood tests. Int J Cancer 2010. [e-pub ahead of print].
31. McQueen A , Vernon SW , Meissner HI et al. Are there gender Differencesin colorectal cancer test use prevalence and correlates? Cancer EpidemiolBiomarkers Prev 2006 ; 15 : 782-91.
32. Stock C , Brenner H. Utilization of lower gastrointestinal endoscopyand fecal occult blood test in 11 European countries: evidence from theSurvey of Health, Aging and Retirement in Europe (SHARE). Endoscopy2010 ; 42 : 546-56.
33. Ahlquist DA , Sargent DJ , Loprinzi CL et al. Stool DNA and occult bloodtesting for screen detection of colorectal neoplasia. Ann Intern Med2008 ; 149 : 441-50.